technical analysis

Look for more sideways price action in the weeks ahead.
Banks, rates and what we think technically at this juncture; plus a look at JPM.
DEO ADRs are poised for a strong upside move; I'll drink to that!
After another technical look at GSK, this FTSE component is still going strong.
Quant downgrade keeps us bearish.
Our strategy on going long BTI and on weakness,
Consider giving energy giant Royal Dutch Shell (RDS) the royal treatment above $56.
More gains await patient CLVS holders.
Biotech has a base pattern than can support a lot more upside..
Prices are extended so don't go long just yet.

Columnist Conversations

SPX weekly View Chart »  View in New Window » $SPX Daily

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.